Researchers in Kenya have discovered a naturally occurring strain of Serratia bacteria that prevents mosquitoes from carrying the malaria parasite. This microbe is transmitted through mating and from mother to offspring, providing a potential self-sustaining biological method for reducing malaria transmission.
TLDR: Scientists identified a specific bacterium, Serratia marcescens HBAD, in wild Kenyan mosquitoes that blocks malaria parasite development. This naturally occurring microbe spreads through mosquito populations and could provide a sustainable, non-chemical tool to significantly reduce human malaria infections without requiring genetic modification of the insects.
Scientists conducting field research in Kenya have identified a naturally occurring bacterium that effectively blocks the transmission of malaria from mosquitoes to humans. The discovery, published in the journal Science, centers on a specific strain of Serratia marcescens known as HBAD. This microbe was found inhabiting the midgut and ovaries of Anopheles mosquitoes, the primary vectors for the malaria parasite.
The research was a collaborative effort involving the International Centre of Insect Physiology and Ecology in Kenya and the pharmaceutical company GSK. During an extensive field expedition, teams collected and analyzed thousands of wild mosquitoes from various regions across the country. They discovered that mosquitoes naturally carrying the HBAD strain were almost entirely free of the Plasmodium parasite, which causes malaria in humans.
Laboratory investigations revealed that the bacterium works by secreting a small molecule called andrimid. This compound interferes with the early stages of the parasite’s development within the mosquito’s gut. By halting the parasite before it can migrate to the insect’s salivary glands, the bacterium prevents the mosquito from passing the infection to a human host during a blood meal.
One of the most significant findings of the study is the bacterium’s ability to spread through mosquito populations. Researchers observed that HBAD is transmitted from male mosquitoes to females during mating. Furthermore, female mosquitoes pass the bacterium to their offspring, ensuring that the next generation also carries the protective microbe. This self-sustaining transmission mechanism suggests that the bacterium could be introduced into wild populations with minimal human intervention.
Unlike traditional malaria control methods, such as chemical insecticides or bed nets, the use of Serratia HBAD does not kill the mosquito. This is a critical advantage, as it reduces the selective pressure that typically leads to the development of insecticide resistance. Because the mosquito remains healthy and able to reproduce, the bacterium can persist in the environment without being outcompeted by non-carrying insects.
The field expedition also highlighted the importance of studying local microbial diversity. The HBAD strain was found in a relatively small percentage of the mosquitoes sampled, suggesting that its presence is influenced by specific environmental factors. Understanding these factors will be essential for determining where and how the bacterium can be most effectively deployed as a public health tool.
The sampling took place in regions including the shores of Lake Victoria, where malaria transmission rates are historically high. Researchers utilized specialized traps and manual collection techniques to gather a diverse array of Anopheles species. By comparing the microbiomes of mosquitoes from different habitats, the team was able to isolate the HBAD strain and confirm its unique properties. This granular approach to field biology allowed the researchers to pinpoint a specific microbial ally in a complex ecological landscape.
The implications for global health are substantial. Malaria remains one of the world’s most devastating diseases, particularly in sub-Saharan Africa, where it claims hundreds of thousands of lives each year. A biological tool that can be naturally dispersed through wild mosquito populations offers a scalable and cost-effective supplement to existing interventions.
Current research efforts are focused on assessing the long-term stability of the bacterium in different ecological settings. Scientists are also conducting safety assessments to ensure that the introduction of HBAD does not have unintended consequences for other insect species or the broader ecosystem. If these studies prove successful, large-scale field trials could begin within the next few years, marking a new chapter in the fight against malaria.

